SCHEMBL6096646

SCHEMBL6096646

O=C1C=C(O)C(=O)C(c2c[nH]c3c2ccc2ccccc23)=C1O

nearest known ligand 0.44

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CSNK2A2 P19784 1/20 0.44
CSNK2B P67870 1/20 0.44
CSNK2A1 P68400 1/20 0.44
NSD2 O96028 1/20 0.36
OPRM1 P35372 1/20 0.36
OPRD1 P41143 1/20 0.36
HKDC1 Q2TB90 1/20 0.36
CDC25A P30304 1/20 0.34
CDC25C P30307 1/20 0.34
ALDH1A1 P00352 3/20 0.34
HPGD P15428 3/20 0.34
KDM4E B2RXH2 2/20 0.34
MAPK1 P28482 2/20 0.34
CYP3A4 P08684 1/20 0.34
MAPT P10636 1/20 0.34
PTPN22 Q9Y2R2 1/20 0.34
XIAP P98170 2/20 0.34
HTT P42858 1/20 0.34
SMN1; SMN2 Q16637 1/20 0.34
AR P10275 3/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6098001 0.82 BRPF1 (0.43) ALDH1A1HPGDKDM4EMAPTHTT
SCHEMBL6096362 0.82 GPR84 (0.40) MAPTARMEN1KMT2A
SCHEMBL6095132 0.82 CLK1 (0.40) XIAPARPIM1
SCHEMBL6096598 0.82 AR (0.41) KDM4EARPRKCBPRKCAPRKCH
SCHEMBL6097125 0.81 PRKCB (0.54) PRKCBPRKCAPRKD3CCNB2CCNE2
SCHEMBL6093340 0.79 XIAP (0.33) CSNK2A2CSNK2BCSNK2A1XIAP
SCHEMBL6095610 0.79 ALDH1A1 (0.47) ALDH1A1HPGDKDM4ECYP3A4MAPT
SCHEMBL6095551 0.77 XIAP (0.38) ALDH1A1HPGDKDM4EMAPK1MAPT
SCHEMBL6095891 0.77 AR (0.34) ALDH1A1XIAPHTTARPRKCB
SCHEMBL6094742 0.76 LTA4H (0.47) XIAP

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7057052-B2 Heterocyclic quinones as pharmaceutical agents DUKE UNIVERSITY (US) 2006-06-06 US disclosed
WO-2004050014-A2 SETEROCYCLIC QUINONES AS PHARMACEUTICAL AGENTS DUKE UNIVERSITY (US) 2004-06-17 WO disclosed
US-20040063774-A1 Heterocyclic quinones as pharmaceutical agents DUKE UNIVERSITY 2004-04-01 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20040063774-A1 Heterocyclic quinones as pharmaceutical agents NQO1, RECQL, SDHA CSNK2A2 3333/4885CSNK2B 3574/4885CSNK2A1 3299/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.